LIPID MAPS uses cookies to keep the site working, to remember your choices, and — only if you allow it — to understand how the site is used so we can improve it. Choose what you are happy with below. You can change your mind at any time from Manage Cookies in the footer.
Register to help us understand how LIPID MAPS resources are used, measure our impact and improve our services.
Compactin is a potent competitive inhibitor of hydroxymethylglutaryl coenzyme A reductase, the rate-limiting enzyme in cholesterol biosynthesis. Experiments were conducted with RAW264.7 cells fed 10% fetal calf serum, as per protocol PP0000002800 (pdf). Measurements were taken at 30m, 1h, 2h, 4h, 8h, 12h, and 24h for: (i) compactin, (ii) Kdo2-Lipid A, (iii) compactin + Kdo2-Lipid A. and (iv) control.
Raetz C, Garrett T, Reynolds C, Shaw W, Moore J, Smith JD, Ribeiro A, Murphy R, Ulevitch R, Fearns C, Reichart D, Glass C, Benner C, Subramaniam S, Harkewicz R, Bowers-Gentry R, Buczynski M, Cooper J, Deems R and Dennis E.
Journal of Lipid Research 47, 1097-1111 (2006)
PMID:16479018 [doi:10.1194/jlr.M600027-JLR200]
This site uses cookies and other tracking technologies to assist with navigation and your ability to provide feedback, analyze your use of our products and services, assist with our promotional and marketing efforts, and provide content from third parties.